These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37942226)

  • 21. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC.
    Xia Y; Wang Y; Xiong Q; He J; Wang H; Islam M; Zhou X; Kim A; Zhang H; Huang H; Tsung A
    Hepatology; 2024 Jan; ():. PubMed ID: 38266270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
    Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC.
    Xia Y; Gao B; Zhang X
    Front Oncol; 2022; 12():993437. PubMed ID: 36212470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
    Lu D; Han C; Wu T
    J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
    Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
    Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma.
    Piccinin E; Arconzo M; Pasculli E; Tricase AF; Cultrera S; Bertrand-Michel J; Loiseau N; Villani G; Guillou H; Moschetta A
    Cell Biosci; 2024 Jun; 14(1):69. PubMed ID: 38824560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAF Prevents Hepatocyte Apoptosis and Hepatocellular Carcinoma through Transcriptional Regulation of the NF-κB pathway.
    Pilarte KA; Reichert EC; Green YS; Halberg LM; McFarland SA; Mimche PN; Golkowski M; Kamdem SD; Maguire KM; Summers SA; Maschek JA; Reelitz JW; Cox JE; Evason KJ; Koh MY
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms in MASLD/MASH-related HCC.
    Wang X; Zhang L; Dong B
    Hepatology; 2024 Feb; ():. PubMed ID: 38349726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans.
    Pan C; Liu J; Gao Y; Yang M; Hu H; Liu C; Qian M; Yuan HY; Yang S; Zheng MH; Wang L
    Cell Metab; 2023 Dec; 35(12):2231-2249.e7. PubMed ID: 38056431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.
    Kishore AH; Owens D; Word RA
    J Clin Endocrinol Metab; 2014 Mar; 99(3):1006-18. PubMed ID: 24471568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.
    Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G
    Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
    Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L
    Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions.
    Ugonabo O; Udoh US; Rajan PK; Reeves H; Arcand C; Nakafuku Y; Joshi T; Finley R; Pierre SV; Sanabria JR
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759769
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Karna S
    Pharmacogn Mag; 2017 Jan; 13(Suppl 1):S122-S126. PubMed ID: 28479736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.
    Etzion O; Bareket-Samish A; Yardeni D; Fishman P
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer.
    Kochel TJ; Goloubeva OG; Fulton AM
    Breast Cancer (Auckl); 2016; 10():61-70. PubMed ID: 27257388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE
    Liang M; Zhan W; Wang L; Bei W; Wang W
    Diabetes Metab Syndr Obes; 2023; 16():3223-3234. PubMed ID: 37867629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion.
    Song BS; Moon JS; Tian J; Lee HY; Sim BC; Kim SH; Kang SG; Kim JT; Nga HT; Benfeitas R; Kim Y; Park S; Wolfe RR; Eun HS; Shong M; Lee S; Kim IY; Yi HS
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
    J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
    Kim HR; Lee HN; Lim K; Surh YJ; Na HK
    Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.